Yorkshire (PRWEB UK) 21 January 2014 Ongoing worldwide research is consistently proving that stem cells will be a cornerstone of medical treatments in the future. Already, literally thousands of stem cell therapies for a host of dangerous and life-threatening conditions have already been successfully performed, and specialists agree that many newly discovered treatments are just around the corner. Stem cells are biological cell types found in multicellular organisms like mammals, and that, of course, includes us. The incredible thing about stem cells is that they are able to divide and change into other types of cell, and this is what gives them their unique ability to repair, or even replace, cells that have been damaged by disease or injury. The potential for the health of younger and future generations is enormous. Although stem cells are found in many different parts of our body, it is the stem cells found in our childrens teeth that are most precious in terms of their potential to safeguard health. While an inevitable crystallisation process makes adult teeth useless for stem cell therapies, first teeth and young wisdom teeth contain tooth pulp in perfect condition to provide useable stem cells. Whats more, children naturally lose … Continue reading →

Tampa, FL (PRWEB) January 21, 2014 Regenerative Medicine Solutions (RMS), a global provider of stem cell treatments for degenerative diseases, is now offering Regenerative ColoTherapy (RCT), a proprietary stem cell treatment for people suffering with celiac and inflammatory bowel disease (IBD). Crohns disease and ulcerative colitis (UC) are two of the most notable conditions that fall under the IBD umbrella, affecting millions of people across the United States and the world. It is estimated that there are 1.4 million cases of Crohns and colitis in the United States, which roughly translates to the population size of Philadelphia. Although Crohns, colitis, and celiac disease are very different conditions, affecting different areas of the intestines, treatment options are similar and mainly consist of diet modification, anti-inflammatories, and immunosuppressants. In severe cases, sufferers use the restroom over 20 times a day and may require surgery to remove part of their intestine or colon. As you can imagine, symptoms of these disorders take a heavy toll on sufferers quality of life. Andrew, a 26-year-old RMS patient that suffers from ulcerative colitis underwent the Regenerative ColoTherapy. For three years, I suffered from diarrhea, bleeding, painful stomach cramping, and being completely drained of energy, Andrew said. … Continue reading →

Pluristem Therapeutics Inc. (PSTI), the Israeli developer of stem-cell therapies, rose the most in more than 17 months after an experimental treatment showed promise in a study of 20 patients with muscle injuries. The stock surged 22 percent to 16.18 shekels ($4.63) at 11:04 a.m. in Tel Aviv. Earlier it gained as much as 27 percent, the biggest increase since Aug. 6, 2012. The shares fell 15 percent yesterday ahead of the study results. The early-stage clinical trial assessing Pluristems placental-expanded, or PLX-PAD, cells in people who had a buttock muscle injured during hip-replacement surgery found the treatment was safe, the company said in a statement today. Patients getting the injection also fared better in a muscle-contraction exercise six months later. These are remarkable results that signal advances in the cell-therapy industry, Jason Kolbert, an analyst with Maxim Group LLC in New York, said at a press conference organized by Pluristem in Tel Aviv. The study results suggest the stem-cell therapy could help treat a broader range of muscle and tendon injuries, according to the Haifa-based company. We intend to move forward with implementing our strategy towards using PLX cells in orthopedic indications and muscle trauma, Chief Executive Officer Zami … Continue reading →

New York, NY (PRWEB) January 21, 2014 Considering that Autism has evaded all determined scientific causal and medical therapeutic efforts to date, a unique medical treatment offered to minimize symptoms in this often debilitating disorder deserves significant attention. Because an inner-ear and related cerebellar fine-tuning impairment was verified to characterize Autism by many researchers, Dr. Levinson chose to treat this signal-scrambling defect utilizing diverse combinations of inner-ear-improving medications and nutrients. He believed the autistic language and communication disorder was akin to an aphasic-like primary cerebral processing defect. And by enhancing signal clarity, Levinson believed residual brain processing capacity would secondarily improve as would the interrelated and collateral symptoms resulting directly from the cerebellar impairment. "In freeing autistics from as many treatable secondary emotional and neurophysiological functional blockers as possible, said Levinson, "I believed autistics would have the best possible chance of maximizing their innate compensatory endowments while stimulating new ones via enhanced neuroplastic changes. There was absolutely nothing to lose by trying, and so much to gain." By choosing to experimentally treat the relatively "minor" cerebellar and related symptomatic fallout now rather than waiting for a primary autistic therapeutic breakthrough nowhere in scientific sight, Levinson also discovered new help and … Continue reading →

Georgia Gov. Nathan Deal (Getty Images) ATLANTA -- Last week, Gov. Nathan Deal said the healthcare plan covering state employees should cover autism treatment -- a move applauded by advocates who say early intervention can improve behavior and quality of life. In his budget this week, Deal would set aside $2.4 million for the coverage. Dozens of other states have passed legislation compelling insurers to provide for the treatments, which can be costly but effective. Research has shown early intervention treatments can prevent or greatly minimize some of the associated disabilities of autism. READ THE PLAN |Governor Deal's education plan and full text of 2014 State of the State speech Georgia is one of only 16 states that don't require the coverage, according to state Rep. Ben Harbin, R-Evans, who is the lead sponsor of "Ava's Law" that would compel insurers in the state to pay for the treatments. The bill is named after Anna Bullard's daughter, who was diagnosed with autism at the age of 2 and who was denied coverage under the state employee health plan in 2006. "That was almost more of a devastating blow than the diagnosis," said Bullard, of Lyons. "The diagnosis was something I … Continue reading →